N-哌嗪烷基酰胺类化合物的合成与DNA相互作用及生理活性

为研究多胺类化合物的抗肿瘤活性, 合成了9个哌嗪烷基酰胺衍生物, 其结构经¹H NMR, MS及元素分析确证. 合成的化合物与三个作为酰化剂的消炎药物萘普生、布洛芬和联苯乙酸及抗癌药物五氟尿嘧啶一并对人口腔上皮癌细胞(KB)、人肺癌细胞(A-549)、乳腺癌细胞(MDA)、人肝癌细胞(Bel-7402)四种肿瘤细胞进行了体外抑制率测试. 结果表明, 所合成的化合物对KB细胞和Bel-7402细胞有正抑制作用, 但对A-549和MDA细胞呈负抑制作用, 意外的是四种商品药物也有类似结果. 还测试了对酪氨酸激酶的抑制作用, 未发现明显活性. 联苯乙酸和N-2-哌嗪基-乙基-4-联苯乙酰胺对DNA荧光光谱的影响表明联苯乙酸可嵌入DNA而后者没有表现出多胺衍生物与DNA的嵌入式作用.     

含氮杂环多芳基咪唑衍生物的合成及其光物理性能

以冰醋酸为溶剂和催化剂,苯偶酰/9,10-菲醌、3-吲哚甲醛/3-咔唑甲醛及醋酸铵经"一锅"反应高效合成了系列含吲哚或咔唑结构单元的多取代咪唑衍生物.考察了反应物配比、溶剂的选择和用量及温度等因素对反应的影响,研究了所合成化合物的光物理性能;筛选出对p H值敏感且结构独特的两个化合物作为p H荧光探针,检测在其作用下MCF-7细胞在不同p H值环境中的荧光成像,结果表明探针2-(9-苄基-9H-咔唑-3-基)-4,5-二苯基-1H-咪唑(2d)和2-(9-苄基-9H-咔唑-3-基)-1H-菲并[9,10-d]咪唑(4)都可用作检测活细胞内p H变化的p H荧光探针.     

熊果酸衍生物的合成及抗肿瘤血管生成活性

对熊果酸C28位与C3位进行结构修饰得到了24个衍生物, 并利用 1H NMR, 13C NMR, MS及HR-MS对这些化合物进行了结构表征. 进一步通过MTT法, 以内皮细胞HUVEC为主要模型, 研究了24个衍生物抗肿瘤血管生成的活性, 同时以A549, Bel-7402及MCF-7细胞为模型研究了上述衍生物对肿瘤细胞的抑制活性. 研究结果表明, 与熊果酸相比, 化合物5, 9, 12e和14e对HUVEC细胞有较好的选择性, 化合物12a和13h比熊果酸的抗肿瘤血管生成活性略高, 因此通过适当改变熊果酸C28位的结构可以提高其对内皮细胞HUVEC的选择性, 增强抗肿瘤血管生成活性. 本文结果表明, 熊果酸及其衍生物是潜在的具有抗肿瘤血管生成作用的先导化合物, 通过有效的结构优化可能得到新型的抗肿瘤血管生成的化合物.     

齐墩果酸和熊果酸衍生物的合成、表征及抗癌活性的研究

根据拼合原理,以天然产物齐墩果酸和熊果酸作为先导化合物,通过丁二酸连接片段,在C-28位分别导入哌嗪、N-甲基哌嗪及吗啉片段,共设计、合成了12种未见文献报道的齐墩果酸和熊果酸衍生物.利用IR、1H NMR、13C NMR和HRMS等波谱技术对所合成的目标化合物进行了结构表征,并采用3-(4,5-二甲基-2-噻唑)-2,5-二苯基溴化四氮唑噻唑蓝(MTT)法观察其对癌细胞的抑制作用,结果表明化合物OA-4、OA-7、OA-8a、OA-8b、UA-4、UA-7、UA-8a和UA-8b对人乳腺癌细胞(MCF-7)、人宫颈癌细胞(Hela)和人肺腺癌细胞(A549)的抑制作用远优于先导化合物齐墩果酸和熊果酸,且OA-4,OA-7,UA-4和UA-7与阳性对照物Gefitinib的IC50值相当.     

熊果酸C-3,C-28位衍生物的合成及其抗肿瘤活性研究

以天然产物熊果酸为原料,经过氧化、酰化、酯化等反应合成了11个未见报道的熊果酸衍生物,其结构经过MS、1H NMR及元素分析确定。以氟尿嘧啶和吉非替尼为阳性对照药,经MTT法对A549和SGC-7901细胞进行初步体外抗肿瘤活性研究。结果表明,目标化合物对两种细胞株的抑制率均明显高于母体化合物,且化合物4b和5a的抑制效果高于阳性对照药,值得进一步研究。     

荧光1,2,4-噻二唑-3,5-二酮衍生物的合成及其对精子的标记作用

合成了3个含有荧光基团的1,2,4-噻二唑-3,5-二酮衍生物,其结构经¹H NMR, ¹³C NMR, HR-MS（ESI）表征,并考察了其对精子的制动活性和荧光标记作用。结果表明：与先导化合物Tideglusib相比,目标化合物均保持了较强的杀精活性,且在紫外光激发下,具有相似的荧光标记模式。     

常春藤皂苷元的糖化学修饰与体外抗COLO205细胞增殖活性

通过连接不同糖片段的三氯乙酰亚胺酯衍生物、甲基衍生物、对甲基苯硫酚衍生物等合成了4个常春藤皂苷元衍生物（4~7,其中6和7为新化合物），其结构经¹H NMR和 ¹³C NMR表征。采用MTT法检测了化合物对人结肠癌细胞COLO205的抑制活性。结果表明：4和5对COLO205细胞有部分抑制作用，与浓度正相关；6对COLO205只在高浓度（1.00×10^-4mmol/L）有较好抑制作用(98.36±0.43%)； 7只在中等浓度(1.00×10^-5 mmol/L)对COLO205有微弱抑制作用(2.75±1.22%)。      

内酯开环塔斯品碱香豆素酯衍生荧光化合物的合成及其抗癌活性

以异香草醛为原料,经溴代、苄基保护、氧化、Ulmman反应和还原等6步反应合成了塔斯品碱内酯开环衍生物（化合物8）。 通过在其结构中分别引入含有2种不同取代基的香豆素衍生物,设计、合成了2个新型荧光性的内酯开环塔斯品碱香豆素酯衍生物（化合物9a和9b）。 产物结构经IR、1H NMR和MS进行了表征。 同时,对产物的荧光特性及其对乳腺肿瘤细胞增殖的抑制活性进行了初步测定。     

粉防己碱衍生物的合成及其抗肿瘤作用研究

以粉防己碱为原料,依次经硝化、还原和Chan-Lam-Evans偶联共计3步反应,设计并合成了12种双苄基异喹啉衍生物,其结构经¹HNMR、¹³CNMR和HR-MS表征。采用MTT法对所得衍生物对人肝癌细胞HepG2、人正常肝细胞HL7702、人肺癌细胞A549的体外抑制活性进行了初步评价。MTT实验结果表明：所得衍生物对癌细胞生长具有较强的抑制作用,并对其构效关系进行了初步评价。化合物7、8对两种癌细胞均有良好的抗肿瘤活性,可能作为一种潜在的抗肝癌药物。其中化合物7对HepG2细胞的抑制作用最强,IC₅₀值为3.72μmol?L^-1,并具有明显的抑制HepG2迁移和侵袭的能力。      

新型常春藤皂苷元衍生物的合成及其体外抗HBV活性

以常春藤皂苷元为原料,对其3,23-羟基和28-羧基进行乙酰化、醚化、苯甲酰化及酯化等反应合成了8个常春藤皂苷元衍生物(2~9),其中6个未见文献报道,其结构经¹H NMR, ¹³C NMR, IR和MS表征。采用MTT法测定了2~9的体外抗HBV活性。结果表明：3~9随浓度增大,对细胞活力的抑制率明显增加,特别是7和9抑制率最明显,用药浓度为1×10^-6mol·L^-1时,抑制率均为9.46±0.47%。对2~9抑制Hep G2.2.15细胞表达表面抗原(HBs Ag)进行了测试。结果表明：2~9对HBs Ag的分泌表达有一定的抑制作用。     

Isolation of fatty acids and aromatics from cell suspension cultures of Lavandula angustifolia

Cell suspension cultures of Lavandula angustifolia Mill. ssp. angustifolia (syn.: L. officinalis Chaix.) afforded a fatty acid composition, cis and trans p-coumaric acids (=p-hydroxy cinnamic acids), and beta-sitosterol. The fatty acid composition was analyzed by GC-MS, and the structures of the isolated three compounds were determined by 1H- and 13C-NMR, and MS spectroscopic techniques.     

Synthesis and Anti-tumor Activity of Novel Amide Derivatives of Ursolic Acid

Ursolic acid was modified at C3 and C28 position to obtain fourteen derivatives including twelve novel compounds, and their chemical structures were characterized by IR, ^1H NMR and MS. Cell growth inhibitory effects of the derivatives against Hela cell were evaluated by MTT assay. All these derivatives were found to have stronger cell growth inhibitory than their parent compound, ursolic acid. The derivatives with a substituted acetyl group at C3 hydroxyl group show better activities than those with an unsubstituted hydroxyl group.     

Synthesis and Biological Evaluation of Novel Tricyclic Oximino Derivatives as Antitumor Agents

A series of novel alkylthio/sulfinyl-8H-thieno[2,3-b]pyrrolizin-8-oximino derivatives Ⅴ1--Ⅷ15 were designed and synthesized as antitumor agents. Their structures were confirmed using IR, ^1H NMR, elemental analysis, and MS. The antitumor activities of all the target compounds were tested by the MTT method in vitro against Bel-7402, HT-1080, SGC-7901, and A549 Cell Lines. Among them, compound Ⅵ9 displayed a promising antitumor activity superior to that of Cisplatin.     

Cell extraction combined with off‐line HPLC for screening active compounds from Coptis chinensis

Cell membrane chromatography is a useful tool for screening active compounds from natural products. As the reason of separation mechanism, traditional cell membrane chromatography could not be used for screening the active compounds absorbed through the cell membrane and influencing the cell signal transduction pathway. In this work, we establish a new method named cell extraction combined with off‐line HPLC for screening the compounds penetrating the cell membrane. This is the first time 3 T3‐L1 adipocyte culture has been combined with HPLC technology. Compared with other cell membrane chromatography methods, there is good resolution and no further analysis by other chromatographic steps is required. On co‐incubating crude extracts of Coptis chinensis with cells and analyzing the compounds extracted by the cells, active compounds such as berberine were detected. Glucose consumption tests showed that berberine could increase glucose consumption by insulin‐resistant 3 T3‐L1 adipocytes. The levels of intracellular berberine correlated with its activity. The results indicate that the developed method could be an alternative method for screening active compounds from natural products. Copyright © 2015 John Wiley & Sons, Ltd.     

Synthesis,antibacterial, anticancer and molecular docking studies of macrocyclic metal complexes of dihydrazide and diketone

The complexes of Co(II), Ni(II), Cu(II) and Zn(II) metal ions has been synthesized through template method by the condensation of succinic acid dihydrazide with 5-chloroisatin in alcoholic medium. Complexes were characterized by C H N analysis, molar conductance, thermal analysis, magnetic susceptibility, mass spectrometry, FTIR, EPR, ¹H NMR, UV–Visible spectroscopy. These studies suggest an octahedral geometry for all the complexes. The compounds were found active against B. subtilis and S. aureus and P. aeruginosa and E. coli bacteria. The Zn(II) complex showed significant anticancer activity against Squamous Cell Carcinoma cells tested by the MTT assay method. Molecular docking studies with EGFR tyrosine kinase were also carried out. All these results show that some of the synthesized compounds have remarkable antibacterial and anticancer property.     

Ultrasound-assisted synthesis and anticancer evaluation of new pyrazole derivatives as cell cycle inhibitors

We designed new pyrazole derivatives as inhibitors of the cell cycle kinases and developed a simple environmentally sustainable synthesis process. We synthesized the pyrazolyl thiourea derivatives using rapid ultrasound mediated methods and confirmed their structures by NMR and IR spectra. The apoptosis and necrosis inducing effects of the new compounds were investigated. Cell cycle analysis and expression of genes involved in apoptosis, cell cycle and xenobiotic metabolism were studied. The compounds presented modest apoptotic effects in human cancer cells. The N-[[3-(4-bromophenyl)-1H-pyrazol-5-yl]carbamothioyl]-4-chloro-benzamide compound (4e) induced a significant increase of cells in G2/M phases in conjunction with an increased expression of cyclin A and cyclin B, emerging as a promising anticancer drug, to be further developed in animal models of cancer.     

Organic Analyses of Highly Radioactive Solutions Requiring Pretreatment by 137Cs Removal

The beta-emitting radionuclide ¹³⁷Cs is precipitated from the Savannah River Site (SRS) high-level waste by adding sodium tetraphenylborate (TPB). The concentrated and washed precipitate slurry containing CsTPB is transferred to Defense Waste Processing Facility (DWPF) Salt Processing Cell and hydrolyzed to yield an aqueous product (PHA) free of benzene. The PHA is highly radioactive (1E+11 dpm) and contains some water-soluble organic compounds that need to be analyzed for process control and process history. High performance liquid chromatography (HPLC) methods were developed to analyze these compounds with instruments contained in unshielded fume hoods. Removing ¹³⁷Cs from PHA in a shielded cell prior to HPLC analyses is essential to minimize personnel radiation exposure. In this study ammonium molybdophosphate (Bio-Rad AMP-1) was used for removing ¹³⁷Cs in PHA (pH 3.8). With a two-step application of AMP slurry, a decontamination factor of 1E+4 was achieved for Cs removal. Two separate HPLC methods were used to analyze four polar organic compounds. The recovery of all the organic compounds were above 85%.     

Phenotypic screening of small molecule libraries by high throughput cell imaging

We have developed high throughput fluorescence cell imaging methods to screen chemical libraries for compounds with effects on diverse aspects of cell physiology. We describe screens for compounds that arrest cells in mitosis, that block cell migration, and that block the secretory pathway. Each of these screens yielded specific inhibitors for research use, and the mitosis screen identified Eg5 as a potential target protein for cancer chemotherapy. Cell imaging provides a large amount of information from primary screening data that can be used to distinguish compounds with different effects on cells, and together with automated analysis, to quantitate compound effects.     

Synthesis,biological evaluation and molecular docking study of dihydropyrimidine derivatives as potential anticancer agents

A series of dihydropyrimidine analogues were prepared via one-pot Biginelli three-component condensation reaction and characterized by NMR, FT-IR, MS spectra, and element analysis. Subsequently, they were screened for in vitro anticancer effect. These analogues revealed good cytotoxic activity against three human cancer cell lines including MCF-7, HepG-2, and A549. Among these analogues, compounds 4d and 4h were the most potent against three cell lines. Cell viability assays indicated 4a and 4c had lower cytotoxicity. In vitro cytotoxicity study on all synthesized compounds demonstrated that introduction of electron withdrawing substituents on C4 position of phenyl ring of dihydropyrimidine contributed to the antiproliferative potency. Moreover, in silico molecular docking results stipulated a sign of good correlation between experimental activity and calculated binding affinity. It proved 4d and 4h as the strongest compounds. Binding modes of analogues proposed the involvement of hydrophobic interactions and hydrogen bonds with Eg5 active site. Structure activity relationship studies indicated that incorporating electron withdrawing substituents on C4 position of phenyl ring of dihydropyrimidine are important for this biological activity.     

两个环己烷螺含氮杂环化合物的合成和晶体结构

环己酮与硫代碳酰肼在不同介质中的反应，合成出两个不同的环己烷螺含氮杂环化合物。经Ｘ－射线结构分析确定它们分别为１，２，４，５－四氮螺［５，５］十一烷－３－硫酮，Ｃ＿７Ｈ＿（１４）Ｎ＿４Ｓ（Ⅰ）和１，２，４，－三氮螺［４，５］癸－１－烯－４－氨基－３－硫酮。Ｃ＿７Ｈ＿（１２）Ｎ＿４Ｓ＿ｘ（Ｓ＿ｘ＝０．８Ｓ＋０．２Ｏ）（Ⅱ）。晶体学参数分别为（Ⅰ）：Ｐ２＿１／ｃ，ａ＝１２．０２６（４），ｂ＝２６．８１７（６），ｃ＝１２．０４２（３），β＝１１５．９４（２）°，Ｚ＝４，Ｖ＝９３３．４（１０），Ｍ＿ｒ＝１８６．２８；（Ⅱ）：Ｐ２＿１／ｍ，ａ＝６．５９５（７），ｂ＝６．８１７（６），ｃ＝１０．５７２（６），β＝１０６．３（１）°，Ｖ＝４５６（１），Ｚ＝２，Ｍ＿ｒ＝１８１．０５。最终一致因子分别为Ｒ＝０．０５４，Ｒ＿ｗ＝０．０６５和Ｒ＝０．０８９，Ｒ＿ｗ＝０．０９６。两个化合物中，环己烷都为椅式构型，它与其螺联的６员氮杂环，５员氮杂环的最小二乘平面间的夹角分别为６８．９４和９０°。并对合成反应途径作了初步讨论。